FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154756500> ?p ?o ?g. }

• W3154756500 endingPage "336" @default.
• W3154756500 startingPage "325" @default.
• W3154756500 abstract "A recent phase III trial did not confirm the previous clinical and endoscopic improvements seen in patients with Crohn’s disease (CD) receiving Mongersen, an oral Smad7 antisense oligonucleotide. Factors accounting for such a discrepancy are unknown. Our objective was to further assess whether Mongersen was effective as induction therapy in active CD and evaluate the in vitro inhibitory effect of various batches of Mongersen used in the previous and present trials on Smad7 expression. In a phase II, open-label study, 18 patients with active CD (Crohn’s Disease Activity Index [CDAI] score > 220 and evidence of endoscopic lesions) received Mongersen 160 mg/day for 12 weeks. The rates of clinical remission, defined as CDAI < 150, and clinical response, defined as a CDAI score decrease ≥ 100, were evaluated at week 4, 8, and 12. The fraction of circulating CCR9-expressing leukocytes was assessed by flow cytometry. Smad7 expression was evaluated in the human colorectal cancer cell line HCT-116 transfected with different batches of Mongersen using real-time polymerase chain reaction (PCR) and Western blotting, The proportions of patients experiencing clinical remission were 38.9%, 55.6%, and 50.0% at week 4, 8, and 12, respectively. At the same time points, the rates of clinical response were 72.2%, 77.8%, and 77.8%, respectively. Mongersen reduced the percentages of CCR9-expressing CD45+ cells. The batch of Mongersen used in this study, but not two batches used in the phase III study, inhibited Smad7 expression in HCT-116 cells. The present findings support the clinical benefit of Mongersen in active CD and show that various batches manufactured during the GED0301 program differ in their ability to inhibit in vitro Smad7. NCT02685683; EudraCT 2015-001693-18" @default.
• W3154756500 created "2021-04-26" @default.
• W3154756500 creator A5005904384 @default.
• W3154756500 creator A5009853619 @default.
• W3154756500 creator A5012646641 @default.
• W3154756500 creator A5022927007 @default.
• W3154756500 creator A5044577178 @default.
• W3154756500 creator A5044820486 @default.
• W3154756500 creator A5053323988 @default.
• W3154756500 creator A5081352904 @default.
• W3154756500 creator A5083849301 @default.
• W3154756500 creator A5086201689 @default.
• W3154756500 creator A5086858016 @default.
• W3154756500 creator A5087405062 @default.
• W3154756500 creator A5087916301 @default.
• W3154756500 creator A5088008401 @default.
• W3154756500 date "2021-04-19" @default.
• W3154756500 modified "2023-10-09" @default.
• W3154756500 title "A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study" @default.
• W3154756500 cites W1969382880 @default.
• W3154756500 cites W1973606162 @default.
• W3154756500 cites W1979081816 @default.
• W3154756500 cites W1982279452 @default.
• W3154756500 cites W1983336154 @default.
• W3154756500 cites W1987064800 @default.
• W3154756500 cites W2026058763 @default.
• W3154756500 cites W2027488963 @default.
• W3154756500 cites W2050431295 @default.
• W3154756500 cites W2072711218 @default.
• W3154756500 cites W2102087425 @default.
• W3154756500 cites W2111570058 @default.
• W3154756500 cites W2112082141 @default.
• W3154756500 cites W2112635226 @default.
• W3154756500 cites W2120549636 @default.
• W3154756500 cites W2135125189 @default.
• W3154756500 cites W2234001938 @default.
• W3154756500 cites W2561041192 @default.
• W3154756500 cites W2595536676 @default.
• W3154756500 cites W2746455149 @default.
• W3154756500 cites W2746807303 @default.
• W3154756500 cites W2803791372 @default.
• W3154756500 cites W2807373833 @default.
• W3154756500 cites W2885174859 @default.
• W3154756500 cites W2886572205 @default.
• W3154756500 cites W2932844691 @default.
• W3154756500 cites W2984128211 @default.
• W3154756500 cites W2989961494 @default.
• W3154756500 cites W2995014054 @default.
• W3154756500 cites W3011438840 @default.
• W3154756500 cites W4211167126 @default.
• W3154756500 cites W4244626580 @default.
• W3154756500 doi "https://doi.org/10.1007/s40259-021-00482-x" @default.
• W3154756500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8084825" @default.
• W3154756500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33871807" @default.
• W3154756500 hasPublicationYear "2021" @default.
• W3154756500 type Work @default.
• W3154756500 sameAs 3154756500 @default.
• W3154756500 citedByCount "11" @default.
• W3154756500 countsByYear W31547565002021 @default.
• W3154756500 countsByYear W31547565002022 @default.
• W3154756500 countsByYear W31547565002023 @default.
• W3154756500 crossrefType "journal-article" @default.
• W3154756500 hasAuthorship W3154756500A5005904384 @default.
• W3154756500 hasAuthorship W3154756500A5009853619 @default.
• W3154756500 hasAuthorship W3154756500A5012646641 @default.
• W3154756500 hasAuthorship W3154756500A5022927007 @default.
• W3154756500 hasAuthorship W3154756500A5044577178 @default.
• W3154756500 hasAuthorship W3154756500A5044820486 @default.
• W3154756500 hasAuthorship W3154756500A5053323988 @default.
• W3154756500 hasAuthorship W3154756500A5081352904 @default.
• W3154756500 hasAuthorship W3154756500A5083849301 @default.
• W3154756500 hasAuthorship W3154756500A5086201689 @default.
• W3154756500 hasAuthorship W3154756500A5086858016 @default.
• W3154756500 hasAuthorship W3154756500A5087405062 @default.
• W3154756500 hasAuthorship W3154756500A5087916301 @default.
• W3154756500 hasAuthorship W3154756500A5088008401 @default.
• W3154756500 hasBestOaLocation W31547565001 @default.
• W3154756500 hasConcept C104317684 @default.
• W3154756500 hasConcept C121608353 @default.
• W3154756500 hasConcept C126322002 @default.
• W3154756500 hasConcept C143998085 @default.
• W3154756500 hasConcept C202751555 @default.
• W3154756500 hasConcept C203014093 @default.
• W3154756500 hasConcept C2779134260 @default.
• W3154756500 hasConcept C2779280984 @default.
• W3154756500 hasConcept C31760486 @default.
• W3154756500 hasConcept C48023723 @default.
• W3154756500 hasConcept C526805850 @default.
• W3154756500 hasConcept C535046627 @default.
• W3154756500 hasConcept C553184892 @default.
• W3154756500 hasConcept C55493867 @default.
• W3154756500 hasConcept C71924100 @default.
• W3154756500 hasConcept C86803240 @default.
• W3154756500 hasConcept C90924648 @default.
• W3154756500 hasConceptScore W3154756500C104317684 @default.
• W3154756500 hasConceptScore W3154756500C121608353 @default.
• W3154756500 hasConceptScore W3154756500C126322002 @default.
• W3154756500 hasConceptScore W3154756500C143998085 @default.

• next